PARIS, Nov 30- France's national drugs agency said on Wednesday it had ordered artificial heart maker Carmat to suspend further implants after a fifth patient died in October. A spokeswoman for the drugs agency said that it had requested further information from the company following the patient's death, which was first reported by Europe 1 radio.
CNBC's Landon Dowdy looks into the cybersecurity of medical devices.
James Dinan, York Capital Management founder and CEO, shares his top stock picks, including St. Jude and Monsanto.
St. Jude has issued warnings about 400,000 of its heart defibrillators after two people died from malfunctions, NBC News reports.
Theranos and its founder Elizabeth Holmes have been sued by one of the blood-testing start-up's biggest backers, according to a WSJ report.
CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.
St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.
Check out the companies making headlines after the bell Tuesday.
HeartWare stock soared more than 90 percent on news that the company will be acquired by Medtronic.
CNBC's Diana Olick takes a look at bringing deskercise to the classroom.
Thermo Fisher Scientific said it would buy FEI for about $4.2 billion to gain access to its signature electron microscopy technology.
An invention that debuted Thursday could let you see all the spots you're missing when you brush.
A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
Bill Ackman should have listened!
Ben Young, Sworkit founder & CEO, explains how a new fitness app allows users to customize personalized workout videos.
Loncar Investments CEO, Brad Loncar says immunotherapy is the most innovative, high-growth area in the biotech space, while describing the company’s ETF.
Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.
Jonathan Adiri, CEO of Healthy.io, discusses how smart phones, wearables and tech will impact health care.